Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment
NCT07105800, Not applicable, Recruiting, Taipei Medical University Shuang Ho Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment | ClinicalTrials.gov |
| NCT number | NCT07105800 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 50 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Taipei Medical University Shuang Ho Hospital | ClinicalTrials.gov |
| Conditions | Older Adults, Cognitive Impairment, Mild | ClinicalTrials.gov |
| Interventions | Music-based dance, Control | ClinicalTrials.gov |
| First posted | 2025-08-06 | ClinicalTrials.gov |
| Last updated | 2026-04-28 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Montreal Cognitive Assessment | Baseline, mid-intervention (week 5), and one week post-intervention (week 10) | The Montreal Cognitive Assessment (MoCA) is a widely used screening tool for detecting Mild Cognitive Impairment (MCI). It evaluates seven cognitive domains through 12 subtests, including: visuospatial and executive Function (e.g., cube copying and clock drawing), naming (e.g., visual confrontation naming), attention and Concentration (e.g., digit span, vigilance tasks), language (e.g., sentence repetition and verbal fluency), abstract Reasoning (e.g., similarity identification), memory (immediate and delayed recall), orientation (temporal and spatial). A total score of 26 or above is considered within the normal cognitive range. According to previous studies, a cut-off score of 24 offers optimal discrimination for MCI, with a reported sensitivity of 92% and specificity of 78%. | ClinicalTrials.gov |
| Secondary | Four-Square Step Test | Baseline, mid-intervention (week 5), and one week post-intervention (week 10) | The FSST assesses motor-cognitive integration and fall risk. Participants are instructed to step rapidly and safely over four squares formed by crossed floor tape in a specified sequence. The test requires directional changes, weight shifting, and quick stepping, engaging both lower limb motor control and executive attention. FSST is widely used in populations with balance impairments, including older adults, individuals with stroke, Parkinson's disease, vestibular disorders, and limb amputations. Cut-off times indicating elevated fall risk vary by population: \>15 sec in older adults and stroke patients, \>9.68 sec in Parkinson's disease, \>12 sec in vestibular disorders, and \>24 sec in amputees. The FSST demonstrates excellent test-retest reliability (ICC = 0.98) and inter-rater reliability (ICC = 0.99) | ClinicalTrials.gov |
| Secondary | Timed Up and Go - Cognitive | Baseline, mid-intervention (week 5), and one week post-intervention (week 10) | This test evaluates dual-task performance by measuring the time needed to stand up from a chair, walk 3 meters, turn, return, and sit down, while performing a cognitive task (counting backward by threes from a random number). It reflects motor-cognitive integration, especially executive function and attention. Times \>15 seconds suggest increased fall risk. One practice trial is provided for instruction comprehension. The test takes approximately 3 minutes and demonstrates excellent test-retest reliability (ICC = 0.96) and strong criterion validity (r = 0.86-0.92) | ClinicalTrials.gov |
| Secondary | Functional Reach Test | Baseline, mid-intervention (week 5), and one week post-intervention (week 10) | The FRT evaluates stability by measuring the maximal forward reach distance while standing with arms extended at 90 degrees and feet shoulder-width apart. The final reach distance is calculated by subtracting the starting fingertip position (third metacarpophalangeal joint) from the furthest reach. Three trials are averaged. Distances \<15 cm indicate high fall risk. Normative values: 14-17 in (ages 20-40), 13-16 in (ages 41-69), and 10-13 in (ages 70-87). The FRT takes approximately 5 minutes to complete and demonstrates strong reliability (test-retest ICC = 0.90-0.95, inter-rater ICC = 0.89) and good face validity (r = 0.71) | ClinicalTrials.gov |
| Secondary | Stroop Color and Word Test | Baseline, mid-intervention (week 5), and one week post-intervention (week 10) | The SCWT measures selective attention, cognitive flexibility, and inhibitory control. It includes three parts: (1) reading color words, (2) naming colored squares, and (3) naming the ink color of incongruent color words (e.g., the word "red" printed in blue ink should be answered as "blue"). Each part is timed for 45 seconds, and performance is scored by the number of correct responses. The test demonstrates high internal consistency (ICC = 0.91), indicating strong reliability | ClinicalTrials.gov |
| Secondary | Course Feedback Questionnaire | One week post-intervention (week 10) | A custom three-item questionnaire developed to collect participant feedback on program experience and perceived benefits. Responses provide qualitative insight into engagement, satisfaction, and perceived change. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 13
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Clock Drawing Task | Primary outcome | ConductCognition |
| Digit Span Test | Primary outcome | ConductCognition |
| Picture Naming Test | Primary outcome | ConductCognition |
| Verbal Fluency | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)